Respiratory neuropathology in Spinocerebellar ataxia type 7.

Expression profiling Neurological disorders Neuroscience Pulmonology Respiration

Journal

JCI insight
ISSN: 2379-3708
Titre abrégé: JCI Insight
Pays: United States
ID NLM: 101676073

Informations de publication

Date de publication:
18 Jul 2024
Historique:
medline: 26 7 2024
pubmed: 26 7 2024
entrez: 25 7 2024
Statut: aheadofprint

Résumé

Spinocerebellar ataxia type 7 (SCA7) is an autosomal dominant neurological disorder caused by a deleterious CAG repeat expansion in the coding region of the ataxin-7 gene. Infantile onset SCA7 leads to severe clinical manifestation of respiratory distress, but the exact cause of respiratory impairment remains unclear. Using the infantile SCA7 mouse model, the SCA7266Q/5Q mouse, we examined the impact of pathological poly-Q-ataxin-7 mutant ataxin-7 on hypoglossal (XII) and phrenic motor units. We identified the transcript profile of the medulla and cervical spinal cord and, investigated the XII and phrenic nerve and the neuromuscular junctions in the diaphragm and tongue. SCA-7 astrocytes showed significant intranuclear inclusions of ataxin-7 in the XII and putative phrenic motor nuclei. Transcriptomic analysis revealed dysregulation of genes involved in amino acid and neurotransmitter transportation and myelination. Additionally, SCA7 mice demonstrated blunted efferent output of the XII nerve and demyelination in both XII and phrenic nerves. Finally, there was an increased number of NMJ clusters with higher expression of synaptic markers in SCA7 mice compared to WT controls. These pre-clinical findings elucidate the underlying pathophysiology responsible for impaired glial cell function and death leading to dysphagia, aspiration and respiratory failure in infantile SCA7.

Identifiants

pubmed: 39053472
pii: 170444
doi: 10.1172/jci.insight.170444
doi:
pii:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Auteurs

Debolina Dipankar Biswas (DD)

Division of Pulmonary and Sleep Medicine, Duke University, Durham, United States of America.

Yihan Shi (Y)

Division of Pulmonary and Sleep Medicine, Duke University, Durham, United States of America.

Léa El Haddad (L)

Division of Pulmonary and Sleep Medicine, Duke University, Durham, United States of America.

Ronit Sethi (R)

Division of Pulmonary and Sleep Medicine, Duke University, Durham, United States of America.

Meredith L Huston (ML)

Division of Pulmonary and Sleep Medicine, Duke University, Durham, United States of America.

Sean Kehoe (S)

Division of Pulmonary and Sleep Medicine, Duke University, Durham, United States of America.

Evelyn R Scarrow (ER)

Division of Pulmonary and Sleep Medicine, Duke University, Durham, United States of America.

Laura M Strickland (LM)

Division of Pulmonary and Sleep Medicine, Duke University, Durham, United States of America.

Logan A Pucci (LA)

Division of Pulmonary and Sleep Medicine, Duke University, Durham, United States of America.

Justin S Dhindsa (JS)

Division of Pulmonary and Sleep Medicine, Duke University, Durham, United States of America.

Ani Hunanyan (A)

Division of Pulmonary and Sleep Medicine, Duke University, Durham, United States of America.

Albert R La Spada (AR)

Departments of Pathology & Laboratory Medicine, Neurology, Biological Chemi, University of California, Irvine, Irvine, United States of America.

Mai K ElMallah (MK)

Division of Pulmonary and Sleep Medicine, Duke University, Durham, United States of America.

Classifications MeSH